Beyond the Data: Colchicine for Post-Op Atrial Fibrillation in COP-AF
David Conen walks Mamas Mamas through the trial results and what they mean for arrhythmia management following thoracic surgery.
Related Articles
Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI
Even at a mean age of 85 years, there is still time to accrue mortality benefits from potent LDL-lowering therapies.
STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios
The three calculators focus on isolated tricuspid repair and replacement, SAVR after TAVI, and multivalve procedures.
STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios
The three calculators focus on isolated tricuspid repair and replacement, SAVR after TAVI, and multivalve procedures.
Statins Might Help in HFpEF—Even in the Absence of ASCVD
Lower risks of death and MACE in statin users are intriguing, but need to be confirmed in randomized trials, experts say.
TCTMD’s Quick Takes: Dr. Monika Safford
Monika Safford, MD, explains how peer coaching and practice facilitation may improve systolic blood pressure for patients in the US “Black Belt.”
The SELECT Trial
Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.
Study Bolsters AF’s Link to Brain Infarcts, Cognitive Impairment
Fighting for sinus rhythm might be crucial for the essential social needs of patients with the arrhythmia, one expert says.
TCTMD’s Top 10 Most Popular Stories for April 2024
All but one of our top stories this month stemmed from ACC 2024, but not all were from the main tent sessions.
Lengthy CPR for In-Hospital Cardiac Arrest Tied to Worse Outcomes
Survival and functional outcome at discharge grow worse by the minute, raising the question of how long is too long.
Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT
For patients who can’t—or won’t—use CPAP, the new findings point toward a tantalizing alternative.